Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevance Health (GB:0HG8)
LSE:0HG8
Holding GB:0HG8?
Track your performance easily
See the Price Targets and Ratings of:
0HG8 Analyst Ratings
Strong Buy
12 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0HG8 Stock 12 Month Forecast
Average Price Target
$603.73
▲(15.62% Upside)
| Highest Price Target$655.00 | Average Price Target$603.73 | Lowest Price Target$530.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stephens
Reiterated
09/05/24
Wells Fargo
Reiterated
09/02/24
Jefferies
Assigned
08/13/24
J.P. Morgan
Reiterated
07/26/24
TD Cowen
Assigned
07/19/24
Truist Financial
Reiterated
07/18/24
Morgan Stanley
Reiterated
07/18/24
Cantor Fitzgerald
Reiterated
07/18/24
Bank of America Securities
Downgraded
07/18/24
Barclays
Reiterated
07/18/24
Mizuho Securities
―
Buy
―
Reiterated
07/17/24
Elevance Health Maintains Strong Outlook Amidst Medicaid Pressures with Outperform Rating Reiterated
RBC Capital
$585
Buy
12.03%
Upside
Reiterated
07/17/24
RBC Capital Keeps Their Buy Rating on Elevance Health (ELV)
Leerink Partners
$620
Buy
18.74%
Upside
Reiterated
07/17/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (NYSE: ELV), CVS Health (NYSE: CVS) and Abbott Laboratories (NYSE: ABT)
Robert W. Baird
$649
Buy
24.29%
Upside
Initiated
05/29/24
Elevance Health initiated with an Outperform at BairdElevance Health initiated with an Outperform at Baird
UBS
$585→$605
Buy
15.86%
Upside
Reiterated
04/19/24
Elevance Health price target raised to $605 from $585 at UBSElevance Health price target raised to $605 from $585 at UBS
Best Analysts Covering Elevance Health
Which Analyst Should I Follow If I Want to Buy GB:0HG8 and Sell After:
1 Month
xxx
Success Rate
12/18 ratings generated profit
Average Return
+2.12%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.12% per trade.
3 Months
xxx
Success Rate
10/14 ratings generated profit
Average Return
+9.17%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +9.17% per trade.
1 Year
Success Rate
14/17 ratings generated profit
Average Return
+17.69%
reiterated a buy rating 11 months ago
Copying George Hill's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +17.69% per trade.
2 Years
xxx
Success Rate
26/26 ratings generated profit
Average Return
+48.67%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +48.67% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0HG8 Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
0
0
0
0
0
Buy
25
25
22
20
17
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
25
23
21
18
Each month's total comprises the sum of three months' worth of ratings.
0HG8 Financial Forecast
0HG8 Stock Forecast FAQ
What is GB:0HG8’s average 12-month price target, according to analysts?
Based on analyst ratings, Elevance Health’s 12-month average price target is $603.73.
What is GB:0HG8’s upside potential, based on the analysts’ average price target?
Elevance Health has 15.62% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Elevance Health a Buy, Sell or Hold?
Elevance Health has a consensus rating of Strong Buy, which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
What is Elevance Health’s share price target?
The average share price target for Elevance Health is $603.73. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $655.00 ,and the lowest forecast is $530.00. The average share price target represents 15.62% Increase from the current price of $522.16.
The highest analyst share price target is $655.00 ,and the lowest forecast is $530.00. The average share price target represents 15.62% Increase from the current price of $522.16.
What do analysts say about Elevance Health?
Elevance Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Elevance Health?
To buy shares of GB:0HG8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.